Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | GFER | P55789 | 1/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 7/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24559531 | 1.00 | LMNA (0.63) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL345588 | 1.00 | LMNA (0.63) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL20789695 | 0.91 | LMNA (0.50) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL10296837 | 0.89 | ALDH1A1 (0.52) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL2763437 | 0.88 | LMNA (0.77) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL649556 | 0.87 | ESR1 (0.60) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL16364512 | 0.87 | ESR1 (0.60) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL20648576 | 0.86 | MEN1 (0.49) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL28789384 | 0.85 | ESR1 (0.58) | LMNAALDH1A1MEN1KMT2AGAA | |
| SCHEMBL17660048 | 0.85 | EPHX2 (0.47) | LMNAALDH1A1MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12240857-B2 | Adamantane derivatives for the treatment of filovirus infection | ARISAN THERAPEUTICS INC. (US) | 2025-03-04 | — | — | US | disclosed |
| US-11844270-B2 | Compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-11844270-B2 | Compound and organic light emitting device including the same | LG DISPLAY CO., LTD. (KR) | 2023-12-12 | — | — | US | disclosed |
| US-20230363261-A1 | LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-09 | — | — | US | disclosed |
| US-20230363261-A1 | LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-09 | — | — | US | disclosed |
| US-11744147-B2 | Light emitting diode and display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-29 | — | — | US | disclosed |
| US-11744147-B2 | Light emitting diode and display device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-29 | — | — | US | disclosed |
| US-20230157155-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| US-20230157155-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20120022080-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | RENASCIENCE CO., LTD. (JP) | 2012-01-26 | — | — | US | disclosed |
| US-7879530-B2 | Antireflective coating composition, antireflective coating, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-02-01 | — | — | US | disclosed |
| US-7879530-B2 | Antireflective coating composition, antireflective coating, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2011-02-01 | — | — | US | disclosed |
| US-7749678-B2 | contains sulfonium compound; improved line edge roughness and pattern profile, and contrast of sensitivity and dissolution in extreme ultraviolet exposure | FUJIFILM CORPORATION (JP) | 2010-07-06 | — | — | US | disclosed |
| US-7749678-B2 | contains sulfonium compound; improved line edge roughness and pattern profile, and contrast of sensitivity and dissolution in extreme ultraviolet exposure | FUJIFILM CORPORATION (JP) | 2010-07-06 | — | — | US | disclosed |
| US-20100151381-A1 | ANTIREFLECTIVE COATING COMPOSITION, ANTIREFLECTIVE COATING , AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100151381-A1 | ANTIREFLECTIVE COATING COMPOSITION, ANTIREFLECTIVE COATING , AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20090087799-A1 | ANTIREFLECTIVE COATING COMPOSITION, ANTIREFLECTIVE COATING, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090087799-A1 | ANTIREFLECTIVE COATING COMPOSITION, ANTIREFLECTIVE COATING, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-1764647-A2 | Positive resist composition for immersion exposure and pattern-forming method using the same | FUJIFILM Corporation (JP) | 2007-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11844270-B2 | Compound and organic light emitting device including the same | TMEM109, CRY1, VDAC1 | LMNA 3142/4885ALDH1A1 54/4885MEN1 1603/4885 |
| US-12240857-B2 | Adamantane derivatives for the treatment of filovirus infection | IFNAR1, MEP1B, MEP1A | LMNA 867/4885ALDH1A1 652/4885MEN1 1731/4885 |
| US-20120022080-A1 | Plasminogen Activator Inhibitor-1 Inhibitor | SERPINE1, SERPINC1, SERPINB1 | LMNA 482/4885ALDH1A1 1450/4885MEN1 844/4885 |
| US-11744147-B2 | Light emitting diode and display device including the same | ALDH1A2, STRA6, DCX | LMNA 3039/4885ALDH1A1 96/4885MEN1 3856/4885 |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | LMNA 2488/4885ALDH1A1 1806/4885MEN1 4794/4885 |
| US-20230363261-A1 | LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME | ALDH1A2, STRA6, DCX | LMNA 3039/4885ALDH1A1 96/4885MEN1 3856/4885 |
| US-20230157155-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE | CRY1, SLC1A2, CHRM1 | LMNA 2290/4885ALDH1A1 12/4885MEN1 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.